4basebio PLC (AIM:4BB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
525.00
0.00 (0.00%)
Jul 24, 2026, 3:53 PM GMT

4basebio Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17.834.63.074.359.59
Cash & Short-Term Investments
17.834.63.074.359.59
Cash Growth
-48.55%1027.53%-29.46%-54.61%-36.10%
Accounts Receivable
0.290.280.110.050.05
Inventory
0.660.370.330.130.16
Other Current Assets
1.921.631.511.360.85
Total Current Assets
20.6636.895.025.910.64
Net Property, Plant & Equipment
4.034.334.23.632.76
Other Intangible Assets
4.833.482.672.121.27
Other Long-Term Assets
0.030.030.030.040.03
Total Assets
29.5544.7311.9211.6914.7
Accounts Payable
1.051.690.690.490.35
Current Portion of Long-Term Debt
--0.390.420.43
Current Portion of Leases
0.130.04---
Other Current Liabilities
1.651.531.190.610.74
Total Current Liabilities
2.833.272.281.521.52
Long-Term Debt
15.6514.2910.072.941.33
Long-Term Leases
0.690.73---
Other Long-Term Liabilities
0.270.050.070.120.16
Total Long-Term Liabilities
16.6115.0810.143.051.48
Total Liabilities
19.4418.3512.414.573.01
Common Stock
13.813.7711.1311.1311.13
Additional Paid-in Capital
52.0951.814.9214.714.57
Accumulated Other Comprehensive Income
-0.16-0.47-0.160.01-0.43
Retained Earnings
-55.63-38.72-26.39-18.73-13.58
Shareholders' Equity
10.1126.38-0.497.1211.7
Total Liabilities & Equity
29.5544.7311.9211.6914.7
Total Debt
16.4715.0710.463.351.76
Net Cash (Debt)
1.3419.54-7.3917.83
Net Cash Growth
-93.16%---87.21%-41.07%
Net Cash Per Share
0.091.49-0.600.080.64
Book Value
10.1126.38-0.497.1211.7
Book Value Per Share
0.652.01-0.040.580.95
Tangible Book Value
5.2922.9-3.16510.42
Tangible Book Value Per Share
0.341.75-0.260.410.85